Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 245

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

SARS‐CoV‐2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG‐I/MDA‐5–MAVS, TLR3–TRIF, and cGAS–STING signaling pathways

Open access
Han, Lulu, Zhuang, Meng‐Wei, Deng, Jian, Zheng, Yi, Zhang, Jing, Nan, Mei‐Ling, Zhang, Xue‐Jing, Gao, Chengjiang, Wang, Pei‐Hui · 2021 · Journal of Medical Virology

Published version of a preprint

Abstract

The suppression of types I and III interferon (IFN) responses by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) contributes to the pathogenesis of coronavirus disease 2019 (COVID‐19). The strategy used by SARS‐CoV‐2 to evade antiviral immunity needs further investigation. Here, we reported that SARS‐CoV‐2 ORF9b inhibited types I and III IFN production by targeting multiple molecules of innate antiviral signaling pathways. SARS‐CoV‐2 ORF9b impaired the induction of types I and III IFNs by Sendai virus and poly (I:C). SARS‐CoV‐2 ORF9b inhibited the activation of types I and III IFNs induced by the components of cytosolic dsRNA‐sensing pathways of RIG‐I/MDA5‐MAVS signaling, including RIG‐I, MDA‐5, MAVS, TBK1, and IKKε, rather than IRF3‐5D, which is the active form of IRF3. SARS‐CoV‐2 ORF9b also suppressed the induction of types I and III IFNs by TRIF and STING, which are the adaptor protein of the endosome RNA‐sensing pathway of TLR3‐TRIF signaling and the adaptor protein of the cytosolic DNA‐sensing pathway of cGAS–STING signaling, respectively. A mechanistic analysis revealed that the SARS‐CoV‐2 ORF9b protein interacted with RIG‐I, MDA‐5, MAVS, TRIF, STING, and TBK1 and impeded the phosphorylation and nuclear translocation of IRF3. In addition, SARS‐CoV‐2 ORF9b facilitated the replication of the vesicular stomatitis virus. Therefore, the results showed that SARS‐CoV‐2 ORF9b negatively regulates antiviral immunity and thus facilitates viral replication. This study contributes to our understanding of the molecular mechanism through which SARS‐CoV‐2 impairs antiviral immunity and provides an essential clue to the pathogenesis of COVID‐19.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jmv.27050

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 33

  1. 10.1038/s41586-020-2012-7 · DOI · Paper page
  2. 10.1016/j.antiviral.2014.06.013 · DOI · Paper page
  3. 10.1126/sciimmunol.abd1554 · DOI · Paper page
  4. 10.1016/j.cell.2020.04.026 · DOI · Paper page
  5. 10.1126/science.abc3545 · DOI · Paper page
  6. 10.1126/science.abc2061 · DOI · Paper page
  7. 10.1016/j.coviro.2012.04.004 · DOI · Paper page
  8. 10.1128/JVI.00016-10 · DOI
  9. 10.1128/JVI.01199-08 · DOI · Paper page
  10. 10.1371/journal.ppat.1000636 · DOI
  11. 10.1007/s13238-014-0026-3 · DOI · Paper page
  12. 10.1371/journal.pone.0030802 · DOI · Paper page
  13. 10.1016/j.immuni.2020.05.013 · DOI · Paper page
  14. 10.1093/cid/ciaa453 · DOI
  15. 10.1016/S0140-6736(20)31042-4 · DOI · Paper page
  16. Abigail Vanderheiden PR, 2020, Type I and type III IFN restrict SARS‐CoV‐2 infection of human airway epithelial cultures, bioRxiv
  17. Lokugamage KG, 2020, SARS‐CoV‐2 is sensitive to type I interferon pretreatment, bioRxiv
  18. 10.1016/j.celrep.2020.107863 · DOI · Paper page
  19. 10.1093/nar/gky186 · DOI
  20. 10.1038/ni.3588 · DOI · Paper page
  21. 10.1038/ni.3641 · DOI · Paper page
  22. 10.15252/embr.201845737 · DOI
  23. Zheng Y, 2020, Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) membrane (M) protein inhibits type I and III interferon production by targeting RIG‐I/MDA‐5 signaling, bioRxiv
  24. 10.1002/jmv.26139 · DOI · Paper page
  25. 10.1074/jbc.AC120.013788 · DOI · Paper page
  26. 10.4049/jimmunol.1303196 · DOI · Paper page
  27. 10.1080/22221751.2020.1780953 · DOI · Paper page
  28. 10.1074/jbc.M109.008227 · DOI · Paper page
  29. 10.1186/s12915-016-0292-z · DOI
  30. 10.1038/s41590-020-0730-5 · DOI · Paper page
  31. 10.4049/jimmunol.180.8.5373 · DOI
  32. 10.1038/srep17554 · DOI
  33. Zhongji Meng TW, 2020, An experimental trial of recombinant human interferon alpha nasal drops to prevent coronavirus disease 2019 in medical staff in an epidemic area, medRxiv

Cited by

See all 245

Metadata

Authors
Han, L., Zhuang, M., Deng, J., Zheng, Y., Zhang, J., Nan, M., Zhang, X., Gao, C., & Wang, P.
Venue
Journal of Medical Virology
Publisher
Wiley
Published
2021-05-09
Volume
93
Issue
9
Pages
5376-5389
ISSN
  • 0146-6615 (ISSN-L)
  • 1096-9071
OpenAlex
W3158953228
Cited by
245
References
12
FWCI
14.28
Type
journal article
Language
en
Open access
bronze
Funders
  • Natural Science Foundation of Jiangsu Province (BK20200225)
  • National Natural Science Foundation of China (31730026, 81525012, 81930039)
  • Natural Science Foundation of Shandong Province (ZR2020QC085)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.